Panacea Biotec Ltd.
Snapshot View

View in App

Prices View details >>

131.60 -4.95 ▼-3.6%

26 September 2022, 04:12:43 PM
Volume: 32,902

Overview View Details >>

Sector Healthcare Compare with Sector peers
Industry Pharmaceuticals & Drugs Compare with Industry peers
Website http://www.panaceabiotec.com
Market Cap 805.14 Cr.
Enterprise Value(EV) 265.82 Cr. 2022-03
Financial Indicators
Earnings per share (EPS) 176.18 Trailing Twelve Months Ending 2022-06
Price-Earning Ratio (PE) 0.76 Trailing Twelve Months Ending 2022-06
Industry PE 30.55 Trailing Twelve Months Ending 2022-06
Book Value / Share 129.41 Trailing Twelve Months Ending 2022-06
Price to Book Value 1.03 Calculated using Price: 133.05
Dividend Yield 0.00 Period Ending 2022-03
No. of Shares Subscribed 6.13 Cr. 61,250,746 Shares
FaceValue 1
Company Profile
The company has product portfolio that's caters therapeutics areas like pain management, diabetes and cardiovascular management, renal disease management, osteoporosis management, anti-tubercular, gastro-intestinal. Business Areas of the Company :- (1) Research and Development (R&D) – Under this the company primarily focuses on New Chemical Entities (NCE), New Biological Entities (NBE) and Novel Drug Delivery System (NDDS). (2) Vaccines- Under this the company has product portfolio of oral polio vaccines and Hepatitis-B vaccines. (3) Formulations- It has created flagship brands like Willgo for pain management, Glizid & Glizid-M for diabetes; Panimun Bioral and Mycept for kidney transplant.

Delivery View Details >>

Delivered Qty
Traded Qty

Performance View Details >>

1 Day
-3.63%
1 Week
-5.80%
1 Month
-2.01%
3 Month
+2.13%
6 Month
-26.19%
1 Year
-54.07%
2 Year
-32.44%
5 Year
-38.78%
10 Year
+10.40%

Ratios View Details >>

9 years 2014-03 2015-03 2016-03 2017-03 2018-03 2019-03 2020-03 2021-03 2022-03
Return on Equity (%) -76.49 -253.03 -34.38 -22.94 11.39 -75.26 347.66
Return on Capital Employed (%) 3.37 0.45 9.93 2.76 2.63 13.44 -0.38 5.36 221.15
Return on Assets (%) -5.47 -4.87 -1.01 -2.97 -4.53 2.55 -13.36 -10.69 73.58

Balance Sheet View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Shh. Funds 626 513 471 449 356 309 350 199 -229 849
Non Curr. Liab. 865 767 918 1,100 719 591 70 741 960 104
Curr. Liab. 510 827 706 475 689 696 938 622 449 803
Minority Int. 7 5 3 1 11 -3 -3 -3 -3 -3
Equity & Liab. 2,008 2,112 2,099 2,025 1,774 1,592 1,356 1,559 1,177 1,752
Non Curr. Assets 1,574 1,739 1,573 1,475 1,071 1,028 848 875 666 712
Curr. Assets 434 373 526 549 703 565 508 683 511 1,041
Misc. Exp. not W/O
Total Assets 2,008 2,112 2,099 2,025 1,774 1,592 1,356 1,559 1,177 1,752

Profit Loss View Details >>

Particulars 10 years 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr. 2022-06 Rs. Cr. TTM
Net Sales 510 687 653 544 593 457 544 625 661 639
Other Income 15 28 20 47 8 5 30 10 11 20
Total Income 525 716 673 591 601 462 574 635 672 659
Total Expenditure -592 -643 -541 -497 -508 -590 -519 -548 -675 -732
PBIDT -67 72 132 94 93 -128 56 87 -3 -72
Interest -150 -105 -127 -101 -101 -105 -174 -185 -181 -134
Depreciation -71 -67 -73 -68 -59 -55 -44 -46 -44 -43
Taxation -2 -3 -2 11 -10 -9 -17 -2 -371 -376
Exceptional Items 177 50 8 334 -15 1,676 1,704
PAT -113 -102 -21 -56 -76 38 -195 -146 1,078 1,079
Minority Interest 1 2 2 2 2 0 0 0 0
Share Associate -1 -6 0 0 0 0 0
Other Related Items
Consolidated Net Profit -112 -107 -18 -54 -74 38 -194 -148 1,078 1,079
Adjusted EPS -18 -17 -3 -9 -12 6 -32 -24 176 176

Cash Flow View Details >>

Particulars 10 years 2013-03 Rs. Cr. 2014-03 Rs. Cr. 2015-03 Rs. Cr. 2016-03 Rs. Cr. 2017-03 Rs. Cr. 2018-03 Rs. Cr. 2019-03 Rs. Cr. 2020-03 Rs. Cr. 2021-03 Rs. Cr. 2022-03 Rs. Cr.
Cash Fr. Operatn. -24 54 37 91 131 118 105 -30 107 -108
Cash Fr. Inv. -61 -38 -37 16 -26 55 -5 -35 -48 1,283
Cash Fr. Finan. 105 -30 -1 -117 -107 -164 -101 91 -47 -1,176
Net Change 20 -14 -1 -10 -2 9 -2 26 12 -2
Cash & Cash Eqvt 35 21 20 10 7 16 14 40 52 50

Shareholding Pattern View Details >>

9 Qtrs 2020-06 (%) 2020-09 (%) 2020-12 (%) 2021-03 (%) 2021-06 (%) 2021-09 (%) 2021-12 (%) 2022-03 (%) 2022-06 (%)
Promoter 73.59 73.59 73.59 73.59 73.59 73.59 73.59 73.59 73.59
Public 26.41 26.41 26.41 26.41 26.41 26.41 26.41 26.41 26.41
Depository Receipts 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Promoter Holding Pledge (%) 69.36 69.36 69.36 94.27 94.27 94.27 94.27 0.00 0.00

Announcements View Details >>

Fri, 09 Sep 2022
General updates
Panacea Biotec Limited has informed the Exchange about update on the USFDA Inspection of the Company???s material Wholly-owned Subsidiary, Panacea Biotec Pharma Limited???s facility at Baddi, Himachal Pradesh, India
Thu, 08 Sep 2022
General updates
Panacea Biotec Limited has informed the Exchange about update on the USFDA Inspection of the Company???s material Wholly-owned Subsidiary, Panacea Biotec Pharma Limited???s facility at Baddi, Himachal Pradesh, India
Thu, 08 Sep 2022
General updates
Panacea Biotec Limited has informed the Exchange about update on the USFDA Inspection of the Company???s material Wholly-owned Subsidiary, Panacea Biotec Pharma Limited???s facility at Baddi, Himachal Pradesh, India

Technical Scans View Details >>

Mon, 26 Sep 2022
Close Crossing Last Week Low Close Crossing Last Week Low
Closing Below Previous Low Closing Below Previous Low
Close Within 52 Week Low Zone Close Within 52 Week Low Zone
High Decrease 6 Months High Decrease 6 Months
High Decrease 1 Year High Decrease 1 Year

Related Stocks View Details >>

Stock Name Market Cap(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. 216,444.01 900.70 -2.2%
Divi's Laboratories Ltd. 97,676.51 3,670.00 +0.8%
Cipla Ltd. 85,998.13 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. 68,714.69 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. 61,530.49 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. 51,200.03 1,512.80 -0.2%
Max Healthcare Institute Ltd. 40,653.72 419.25 -1.8%
Stock Name Statement TTM Ending Price Earning Ratio(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 55.65 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 31.45 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-06 34.59 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 23.00 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 69.65 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 64.10 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 64.55 419.25 -1.8%
Stock Name Statement TTM Ending Price To Book Value(TTM) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-06 4.32 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-06 7.86 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-06 4.00 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-06 3.40 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-06 10.35 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-06 8.03 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-06 6.33 419.25 -1.8%
Stock Name Statement Year Ending Debt Equity Ratio LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 0.02 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 0.00 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 0.04 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 0.18 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 0.47 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 0.68 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 0.12 419.25 -1.8%
Stock Name Statement Year Ending Return On Equity(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 419.25 -1.8%
Stock Name Statement Year Ending Return On Capital Employed(%) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 7.21 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 28.16 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 13.10 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 11.55 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 21.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 13.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 10.19 419.25 -1.8%
Stock Name Statement Year Ending Net Sales(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 38,654.49 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 8,959.83 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 21,763.34 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 21,545.20 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 14,662.60 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 8,508.04 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 3,931.46 419.25 -1.8%
Stock Name Statement Year Ending Profit After Tax(Rs. Cr.) LTP Chg %
Sun Pharmaceutical Industries Ltd. Consolidated 2022-03 3,405.82 900.70 -2.2%
Divi's Laboratories Ltd. Consolidated 2022-03 2,960.45 3,670.00 +0.8%
Cipla Ltd. Consolidated 2022-03 2,559.47 1,065.65 -0.2%
Dr. Reddy's Laboratories Ltd. Consolidated 2022-03 2,112.20 4,127.85 -0.3%
Apollo Hospitals Enterprise Ltd. Consolidated 2022-03 1,101.10 4,282.70 -3.1%
Torrent Pharmaceuticals Ltd. Consolidated 2022-03 777.18 1,512.80 -0.2%
Max Healthcare Institute Ltd. Consolidated 2022-03 605.05 419.25 -1.8%

FAQ's On Panacea Biotec Ltd.

What is Panacea Biotec share price?
Can I buy Panacea Biotec shares now?
What is the Market Cap of Panacea Biotec?
What are the key metrics to analyse Panacea Biotec?
What is the 52 Week High and Low of Panacea Biotec?
What is the trend of Panacea Biotec share price?